The novel approach of tirzepatide peptide represents a exciting breakthrough in the management of type 2 diabetes. Unlike existing medications, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide646263.blogdemls.com/41819504/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment